United States · FDA National Drug Code directory
Glatiramer Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0832-6084_991aa361-3f99-42cd-948b-5b1271b346c5
- Product NDC
- 0832-6084
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Glatiramer Acetate Injection
- Labeler
- UPSHER-SMITH LABORATORIES, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260123
- Source listing expiry
- 20271231
Source-listed ingredients
- GLATIRAMER ACETATE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 SYRINGE, GLASS in 1 CARTON (0832-6084-30) / 1 mL in 1 SYRINGE, GLASS (0832-6084-89) · 0832-6084-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →